EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Methotrexate in Atherogenesis and Cholesterol Metabolism

Eric Coomes, Edwin S L Chan, Allison B Reiss

Cholesterol · 2011

DOI: 10.1155/2011/503028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cholesterol, 2011. Verfasst von Eric Coomes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Translational Medicine, New York University School of Medicine, NBV 16N1, 550 First Avenue, New York, NY 10016, U…. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NIAMS NIH HHS, NCRR NIH HHS, National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methotrexate is a disease-modifying antirheumatic drug commonly used to treat inflammatory conditions such as rheumatoid arthritis which itself is linked to increased cardiovascular risk. Treatments that target inflammation may also impact the cardiovascular system. While methotrexate improves cardiovascular risk, inhibition of the cyclooxygenase (COX)-2 enzyme promotes atherosclerosis. These opposing cardiovascular influences may arise from differing effects on the expression of proteins involved in cholesterol homeostasis. These proteins, ATP-binding cassette transporter (ABC) A1 and cholesterol 27-hydroxylase, facilitate cellular cholesterol efflux and defend against cholesterol overload. Methotrexate upregulates expression of cholesterol 27-hydroxylase and ABCA1 via adenosine release, while COX-2 inhibition downregulates these proteins. Adenosine, acting through the A 2A and A 3 receptors, may upregulate proteins involved in reverse cholesterol transport by cAMP-PKA-CREB activation and STAT inhibition, respectively. Elucidating underlying cardiovascular mechanisms of these drugs provides a framework for developing novel cardioprotective anti-inflammatory medications, such as selective A 2A receptor agonists.

Autor:innen und Institutionen

  • Department of Medicine, Division of Translational Medicine, New York University School of Medicine, NBV 16N1, 550 First Avenue, New York, NY 10016, USA.

Förderung

  • NIAMS NIH HHS
  • NCRR NIH HHS
  • National Institutes of Health

Zitieren

APA

Coomes, E., Chan, E. S., & Reiss, A. B. (2011). Methotrexate in Atherogenesis and Cholesterol Metabolism. Cholesterol. https://doi.org/10.1155/2011/503028

Vancouver

Coomes E, Chan ES, Reiss AB. Methotrexate in Atherogenesis and Cholesterol Metabolism. Cholesterol. 2011. doi:10.1155/2011/503028

BibTeX
@article{Coomes2011,
  author = {Coomes, Eric and Chan, Edwin S L and Reiss, Allison B},
  title = {Methotrexate in Atherogenesis and Cholesterol Metabolism},
  journal = {Cholesterol},
  year = {2011},
  doi = {10.1155/2011/503028}
}
Kostenlos starten →